Design and Sensing Performance of Single DNA Probe N C B S (CBA@AAO).
The design strategy for the solid-state NCBS functionalized with single DNA probes CBA@AAO is shown in Figure S1. And the successful preparation of CBA@AAO was demonstrated in detail by SEM, EDS mapping, XPS, contact Angle and electrochemical tests (See Supporting Information for details). Subsequently, to demonstrate that the ultra-sensitivity of CBA@AAO to the target molecule is due to the specific probe CBA, we used a PolyA DNA sequence with the same number of bases as CBA but consisting entirely of adenine bases (PolyA) and grafted it onto the AAO membranes. We compared the current signal changes of CBA@AAO and PolyA@AAO after exposure to 1 fM and 1 pM Cathinone (Cat). The current increased with different concentrations of Cat for CBA@AAO, whereas PolyA@AAO showed no significant changes (Fig. 2A). Moreover, we further explored the transmembrane ionic current stability after CBA@AAO recognition of different concentrations of Cat. As shown in Fig. 2B, the ionic current increased with the increase in Cat concentration, mainly due to the increase in the effective diameter of the nanochannels resulting from the structural changes induced by probe binding to the target.
We investigated the direct detection of Cat, and the transmembrane current results demonstrated a decrease in current after CBA@AAO recognized Cat (Fig. 2C). And direct detection of Cat transmembrane transport showed a decreasing trend in I-T signal with increasing concentration. As shown in Fig. 2D, at high Cat concentrations, during the process of CBA as a specific binding probe transporting Cat, it gradually blocks the nanochannel and shields the negatively charged surface of the nanochannels, leading to varying degrees of pore blockage.[55] The primary influencing factor for probe-modified NCBS is the size effect. CBA@AAO with pore sizes ranging from 40 ~ 70 nm exhibited the optimal response to Cat, with current signal change rates of 10.1% at 1 fM and 22.4% at 1 nM concentrations (Fig. 2E). This superior performance can be attributed to the appropriate pore size and porosity, which play crucial roles during the functionalization process. An optimal combination of these factors ensures not only adequate surface area for CBA modification on the NCBS but also sufficient probe functionalization within the pores (Figure S5, Table S9).
To emphasize the sensing performance of the CBA@AAO NCBS for detecting the target, we examined the relationship between transmembrane ionic current and Cat concentration. The results demonstrated a strong linear response of CBA@AAO over the Cat concentration range of 1 ~ 104 fM (R2 = 0.9984), with a detection limit as low as 0.40 fM (Figs. 2F, S17). This indicates the ultra-sensitivity and effectiveness of the NCBS for ultra-trace detection of Cat. Specificity is crucial in evaluating probe sensor performance. We tested the CBA@AAO binding to methcathinone (Met) and ethcathinone (Eth), which share similar structures with Cat. As shown in Fig. 2G, at 1 fM Cat, the current ratio before and after recognition was 1.10, whereas for Met and Eth, the ratios were only 1.03 and 1.01, respectively, at 105 fM. And the ratio increased to 1.23 at 105 fM Cat. We also compared responses to 11 other drugs, including norketamine (Nor), ketamine (Ket), amphetamine (Amp), MDMA, phenacetin (Phe), cocaine (Coc), heroin (Her), caffeine (Caf), procaine (Pro), paracetamol (Par), and (+)-pseudoephedrine (PSE) (Figures S19-21). CBA@AAO showed strong selectivity for Cat, with varying responses to other substances, likely due to differences in structural features (such as the number and position of amino groups, conjugated structures, etc.).
We successfully differentiated Cat, Met, and Eth using principal component analysis (PCA) based on variations in current signals before and after CBA@AAO response (Figure S24). The distribution of clusters corresponded with increasing concentrations, achieving 94% accuracy (Table S25). Building on this, we applied PCA to 14 different drugs at the same concentration, achieving 100% correct classification (Figure S23, Table S24). Additionally, hierarchical cluster analysis (HCA), an unsupervised multivariate method,[56, 57] was used to distinguish analytes through dimensionality reduction (Fig. 2H). These findings indicate that, beyond specific Cat recognition, the CBA@AAO NCBS exhibits cross-reactivity to structurally similar drugs, offering potential for discriminative analysis in complex environments.
Sensing Properties of C4@AAO and CBA&C4@AAO at Different pH Levels
To address pH interference in Cat recognition, we introduced a pH-responsive specific probe (C4 DNA) and functionalized on NCBS, creating the C4@AAO sensor. As shown in Fig. 3A, the C4@AAO exhibited significant variations in I-V characteristics in response to different pH levels. At + 2 V, the transmembrane current varied notably: 85.6 ± 1.3 µA at pH 3 (open state) and 20.2 ± 0.1 µA at pH 8 (closed state). The C4-NCBS also showed a strong linear response between pH 3 ~ 7 (R2 = 0.9881) (Fig. 3B), attributed to pH-induced structural changes in C4 DNA. Cyclic stability tests at pH 5.5 and 7.5 confirmed the C4-NCBS robust and reliable performance in pH analysis (Figs. 3C, S25).
To achieve co-calibration for ultra-sensitive Cat detection and pH interference resistance, we developed the CBA&C4@AAO by co-grafting CBA and C4 DNA onto NCBS. The biosensor is capable of simultaneously sensing the target and pH changes. We investigated the ionic current changes of CBA@AAO and CBA&C4@AAO before and after target binding under different pH conditions (Fig. 3D). The current measurements were based on I-V characteristics, reflecting the transmembrane ionic current changes before and after Cat recognition at + 2 V. The results showed that the incorporation of C4 DNA led to a significant increase in the current variation upon target recognition, compared to CBA@AAO. As shown in Fig. 3E, at pH 5.5 and 7.5, the current changes of CBA&C4@AAO after Cat binding were 20.79 µA and 15.42 µA, respectively, while for CBA@AAO, the changes were only 16.37 µA and 9.48 µA. The CBA provides target specificity, while C4 DNA responds to protons, reducing interference caused by ion transport. By compensating for the pH-induced ionic current changes, the sensitivity of CBA&C4@AAO to Cat recognition was significantly enhanced under varying pH conditions (Figs. 3F, S28). At pH 5.5, the current signal increased by 14%, 31%, and 80% for 1 fM, 1 pM, and 1 nM Cat, respectively. At pH 7.5, the signal increases were even more pronounced, reaching 159%, 201%, and 322%. These findings indicate that the CBA&C4@AAO exhibits excellent potential in resisting pH interference during Cat detection, offering a promising approach to further enhancing NCBS sensitivity.
We assessed the linear response ranges and minimum detection limits of two NCBS under pH 7.4 and 5.5 levels. As shown in Fig. 3G, the CBA&C4@AAO exhibited a broader linear response range compared to CBA@AAO at pH 7.4. Similarly, at pH 5.5, the transmembrane current change of CBA&C4@AAO upon binding to Cat was significantly higher than that of CBA@AAO, with a wider linear response range (Fig. 3H). This enhancement is primarily attributed to the introduction of C4 DNA, which slightly reduces the hydrophilicity of the nanochannels membrane, thereby lowering the initial current signal threshold. Additionally, C4 DNA provides numerous hydrion binding sites, mitigating the interference from proton transport. The mixed modification, due to the different lengths of the two DNA strands, increases the probe modification density, resulting in a more uniform charge distribution on the membrane surface. Consequently, the changes in nanochannels size, surface wettability, and surface charge before and after the binding of Cat in CBA&C4@AAO synergistically enhance the detection signal. The CBA@AAO displayed a linear response range of 1 ~ 104 fM with a limit of detection (LOD) of 0.40 fM, while CBA&C4@AAO had a linear range of 0.1 ~ 107 fM and an LOD of 1.25 fM at pH 7.4. At pH 5.5, CBA@AAO exhibited a linear range of 10 ~ 105 fM with an LOD of 4.78 fM, whereas CBA&C4@AAO showed a linear range of 1 ~ 108 fM and an LOD of 5.24 fM (Fig. 3I). Although the mixed modification slightly reduced the LOD, it significantly expanded the linear response range, optimizing the co-calibration strategy for enhancing sensitivity based on DNA probes.
Sensing Mechanism of NB Modified by DNA Probes
To investigate the reasons for the enhancement of sensitivity and specificity of the probes-NCBS, we used molecular docking to predict the binding mode and binding sites of the ligand interacting with the macro-molecule. Molecular docking studies can further provide information on the binding affinity between Cat and DNA. As shown in Fig. 4B, the molecular docking results indicate that CBA interacts with Cat through groove binding, primarily through non-covalent interactions (including hydrogen bonds and van der Waals forces), with a binding energy of ~ 5.6 kcal·mol− 1. This is consistent with the results obtained from circular dichroism (CD) measurements, indicating a conformational change upon binding of CBA to the target Cat (Fig. 4C). With the continuous increase in Cat concentration, the CD signal change becomes more pronounced, accompanied by an increase in corresponding UV absorption (Fig. 4D). Therefore, the proposed mechanism primarily involves the change in the effective diameter of the nanochannel before and after recognition. During the sensing process, when voltage is applied on both sides of CBA@AAO, ions are driven to pass through the nanochannel, resulting in an open-circuit current signal. The current I of the nanochannel can be mathematically represented by formula (1),[58] as the system can be reduced to a model of ionic conductance for a cylindrical channel:
I = V ([n+µ+ + n−µ−] e) ( \(\:\frac{4h}{\pi\:{d}^{2}}\)+ \(\:\frac{1}{d}\))−1 + \(\:\frac{V\mu\:\otimes\:\pi\:d\sigma\:}{h}\) (1)
According to previous studies,[59] when the thickness h of the nanochannel is significantly greater than its diameter d, formula (1) can be simplified to the following equation:
I = V (\(\:\frac{4h}{\pi\:{d}^{2}}\))−1 (2)
Where V is the applied voltage; n+ and n− represent the number densities of positive and negative ions, respectively; µ+ and µ− represent the electrophoretic mobilities of positive and negative ions, respectively; e is the elementary charge; h and d are the thickness and diameter of the nanochannel. The last term in formula (1) explains the transport of ions through a highly charged inner surface, where µ represents the solution mobility of counterions adsorbed on the charged surface, and σ is the surface charge density, with its sign opposite to that of the counterions. Eq. (2) indicates that the diameter d plays a crucial role in determining the current through the nanochannel. In this work, d represents the effective diameter. Figure 4A discusses the relationship between I and the d before and after the CBA@AAO sensor recognizes the target. Before target recognition, the probe is stretched and in a dispersed state, leading to obstruction of the nanochannel current. Upon binding with Cat, the CBA probe adopts a hairpin structure, resulting in an increase in nanochannel current. The current ratio (R) and the current change (ΔI) for target recognition by the sensor can be expressed as follows:
R = I1 / I0 (3)
ΔI = I1 - I0 (4)
Where I1 and I0 represent the current values measured before and after the binding of CBA@AAO with Cat, respectively. By combining equations (2), (3), and (4), the current ratio and current change for the probe-NCBS upon target recognition can be calculated as follows:
R = \(\:\frac{{\left(d+\:\varDelta\:d\right)}^{2}}{{d}^{2}}\) > 1 (5)
ΔI > 0 (6)
The significant increase in current observed after Cat binds to the CBA@AAO can be attributed to the increase in the d of the nanochannel. To further demonstrate the specificity of the NCBS, we conducted CD tests using PolyA in response to different concentrations of Cat. The results indicated that PolyA did not show significant changes in CD signal due to the presence of Cat (Fig. 4E). Additionally, we examined the CD properties of Met, Eth, and Nor, which have similar structures to Cat, when interacting with CBA. The experimental results showed slight changes in the CD signals for Met and Eth.
Under higher pH conditions, C4 DNA adopts an extended linear conformation, partially blocking the nanochannels. As the pH decreases, the aptamer senses and binds to protons, causing C4 DNA to fold into an i-Motif structure, thereby increasing the effective pore size of the nanochannels (Fig. 4F). This structural transition was confirmed by circular dichroism (CD) spectroscopy. As shown in Fig. 4G, the CD characteristics remain the same at pH 3.5 and 7.5, indicating similar probe conformations. This is the most stable conformation of DNA under physiological conditions, with B-form DNA showing a negative peak around 250 nm and a positive peak around 275 nm.[60, 61] When the pH drops from 5.5 to 4.5, the CD results show the negative peak shifting from 253 nm to 250 nm and the positive peak from 285 nm to 275 nm, indicating a structural transition from B-form to Z-form and back to B-form, leading to a final conformational change.[62–64] Fig. 4H illustrates the response mechanism of the dual-aptamer calibrated NCBS for pH-interference-resistant Cat detection. C4 DNA binds to hydrion, reducing signal interference from mass transport, while CBA provides target specificity. By minimizing pH-induced ionic current interference, the CBA&C4@AAO significantly enhances sensitivity to Cat under different pH conditions.
Application of Co-Calibration Strategy in Complex System
Interference-free detection of target substances in complex environments is a key factor in evaluating sensor performance. For drug detection through sweat, this non-invasive method offers significant potential due to its lack of privacy concerns. However, since human sweat typically has a pH range of 3 ~ 8, pH-related signal interference remains a challenge for sensors in practical applications. To address this, we used the CBA&C4@AAO to detect various concentrations of Cat in artificial sweat. As shown in Fig. 5A, the NCBS exhibited a strong linear response between 1 pM ~ 100 nM, with R2 = 0.9944. We selected Met, Eth and Nor, which are structurally like the Cat, as reference, while glucose (Glu) and lactate (Lac), which are common in sweat, were selected as disruptors. The results showed that the current change after incubation with Cat was 1.56 µA, while the signal change for other substances was no more than 36.32% of the target signal (Fig. 5B). This indicates that the NCBS produces distinct electrochemical responses for different analytes, forming the basis for discrimination. To further evaluate its discriminative capability, linear discriminant analysis (LDA) and hierarchical cluster analysis (HCA) were performed. The LDA results successfully differentiated the six substances in the complex mixture with an accuracy of 97% (Fig. 5C, Table S26). The HCA dendrogram visually conveyed the relationships between analytes, effectively illustrating the chemical similarities (Fig. 5D).
Additionally, to compare the sensitivity of the NCBS prepared through mixed modification, we further employed asymmetric modification by immobilizing C4 DNA and CBA on opposite sides of the nanochannels (Fig. 5F). At + 2 V, the NCBS current signal increased by 78.8 ± 3.4% at pH 5.5 and by 251.0 ± 3.7% at pH 7.5 after detecting 1 nM Cat, indicating that asymmetric modification enhances sensitivity under acidic conditions. We also evaluated the NCBS response to different concentrations of Cat in artificial sweat. As shown in Fig. 5G, the signal change rates increased with Cat concentration, reaching 29.6 ± 4.7%, 38.5 ± 1.1%, and 48.8 ± 1.5% at 1 fM, 1 pM, and 1 nM, respectively. These results demonstrate that the CBA&C4@AAO prepared via this functionalization strategy maintains excellent recognition ability for Cat in complex environments. The dual aptamer-functionalized NCBS, employing a co-calibration strategy for Cat recognition and pH interference resistance, exhibited outstanding sensing performance. This sensing strategy not only achieved a wider target concentration response range but also significantly improved the detection limit by 4 ~ 5 orders of magnitude compared to recent drug detection methods (Fig. 5E, Table S27).[S1−S10] Thus, it holds great promise for drug detection in sweat, drug control, and health monitoring.